9 Nov 2022 , 08:25 AM
Net profit of Ind-Swift Laboratories rose 3.56% to Rs 25.34 crore in the quarter ended September 2022 as against Rs 24.47 crore during the previous quarter ended September 2021. Sales rose 31.65% to Rs 310.21 crore in the quarter ended September 2022 as against Rs 235.64 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 310.21 | 235.64 | 32 |
| OPM % | 18.94 | 23.79 | – |
| PBDT | 42.32 | 39.01 | 8 |
| PBT | 25.91 | 25.10 | 3 |
| NP | 25.34 | 24.47 | 4 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
